NO20091625L - Polymorf B pa N-(2-fluoro-5-[3-(tiopen-2-karbonyl)-pyrazolo[1,5-A]pyrimidin-7-yl]-fenyl)-N-metylacetamid - Google Patents
Polymorf B pa N-(2-fluoro-5-[3-(tiopen-2-karbonyl)-pyrazolo[1,5-A]pyrimidin-7-yl]-fenyl)-N-metylacetamidInfo
- Publication number
- NO20091625L NO20091625L NO20091625A NO20091625A NO20091625L NO 20091625 L NO20091625 L NO 20091625L NO 20091625 A NO20091625 A NO 20091625A NO 20091625 A NO20091625 A NO 20091625A NO 20091625 L NO20091625 L NO 20091625L
- Authority
- NO
- Norway
- Prior art keywords
- polymorph
- pyrazolo
- pyrimidin
- fluoro
- carbonyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Det beskrives en ny polymorf av N-{2-f[uor-5-[3-(tiofen-2-karbonyl)-pyrazolo[l,5-a]pyrimidin-7-yl-fenyl}-N-metyl-acetarnid. Videre beskrives det fremgangsmåter for fremstilling av polymorfen, dens anvendelse som et medikament, dens bruk ved fremstilling av et medikament, og farmasøytiske preparater inneholdende den nye polymorf.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85074306P | 2006-10-11 | 2006-10-11 | |
EP06122138A EP1918290A1 (en) | 2006-10-11 | 2006-10-11 | Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide |
PCT/EP2007/060797 WO2008043800A1 (en) | 2006-10-11 | 2007-10-10 | Polymorph b of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-n-methyl-acetamide |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20091625L true NO20091625L (no) | 2009-05-07 |
NO342008B1 NO342008B1 (no) | 2018-03-12 |
Family
ID=37789824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20091625A NO342008B1 (no) | 2006-10-11 | 2009-04-23 | Polymorf B av polymorf B av N-{2-fluor-5-[3-(tiofen-2-karbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]-fenyl)-N-metyl-acetamid |
Country Status (21)
Country | Link |
---|---|
US (2) | US8039476B2 (no) |
EP (2) | EP1918290A1 (no) |
JP (1) | JP5171831B2 (no) |
KR (1) | KR101418624B1 (no) |
CN (1) | CN101622257B (no) |
AR (1) | AR063231A1 (no) |
AU (1) | AU2007306319B2 (no) |
BR (1) | BRPI0717833A2 (no) |
CA (1) | CA2666653C (no) |
CL (1) | CL2007002928A1 (no) |
DK (1) | DK2081935T3 (no) |
ES (1) | ES2637137T3 (no) |
MX (1) | MX2009003571A (no) |
NO (1) | NO342008B1 (no) |
PL (1) | PL2081935T3 (no) |
PT (1) | PT2081935T (no) |
RU (1) | RU2413729C2 (no) |
SI (1) | SI2081935T1 (no) |
TW (1) | TWI391392B (no) |
UY (1) | UY30637A1 (no) |
WO (1) | WO2008043800A1 (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1921079A1 (en) * | 2006-11-08 | 2008-05-14 | Ferrer Internacional, S.A. | Amorphous form of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide |
JP5149376B2 (ja) * | 2008-03-31 | 2013-02-20 | 京セラ株式会社 | 太陽電池素子及び太陽電池モジュール |
IT1391113B1 (it) * | 2008-09-30 | 2011-11-18 | Dipharma Francis Srl | Procedimento per la preparazione di azelnidipina cristallina |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US399621A (en) * | 1889-03-12 | Canning-house truck | ||
US6399621B1 (en) * | 1999-08-10 | 2002-06-04 | American Cyanamid Company | N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
CZ2002783A3 (cs) * | 1999-09-02 | 2004-01-14 | Neurocrine Biosciences, Inc. | Polymorfy N-methyl-N-[3-[3-(2-Thienylkarbonyl)pyrazol-[1,5-alfa]-pyrimidin-7-yl]fenyl]acetamid a prostředky a způsoby s tím související |
DE60309332T2 (de) * | 2002-08-26 | 2007-05-24 | Neurocrine Biosciences, Inc., San Diego | POLYMORPH VON N-METHYL-N-(3- 3-i2-THIENYLCARBONYLö-PYRAZOL-i1,5-ALPHAö-PYRIMIDIN-7-YL PHENYL)ACETAMID UND ZUSAMMENSETZUNGEN SOWIE VERFAHREN HIERZU |
WO2006044903A1 (en) * | 2004-10-18 | 2006-04-27 | Neurocrine Biosciences, Inc. | HYDRATE OF N-METHYL-N-(3-{3-[2-THIENYLCARBONYL]-PYRAZOL-[1,5-α]- PYRAMIDIN-7-YL}PHENYL)ACETAMIDE AND PROCESSES AND METHODS RELATED THERETO |
EP1736475A1 (en) * | 2005-06-21 | 2006-12-27 | Ferrer Internacional, S.A. | Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates |
-
2006
- 2006-10-11 EP EP06122138A patent/EP1918290A1/en not_active Withdrawn
-
2007
- 2007-10-10 DK DK07821164.6T patent/DK2081935T3/en active
- 2007-10-10 RU RU2009117716/04A patent/RU2413729C2/ru not_active IP Right Cessation
- 2007-10-10 ES ES07821164.6T patent/ES2637137T3/es active Active
- 2007-10-10 PT PT78211646T patent/PT2081935T/pt unknown
- 2007-10-10 WO PCT/EP2007/060797 patent/WO2008043800A1/en active Application Filing
- 2007-10-10 CA CA2666653A patent/CA2666653C/en not_active Expired - Fee Related
- 2007-10-10 MX MX2009003571A patent/MX2009003571A/es active IP Right Grant
- 2007-10-10 CN CN2007800378418A patent/CN101622257B/zh not_active Expired - Fee Related
- 2007-10-10 AU AU2007306319A patent/AU2007306319B2/en not_active Ceased
- 2007-10-10 SI SI200731955T patent/SI2081935T1/sl unknown
- 2007-10-10 PL PL07821164T patent/PL2081935T3/pl unknown
- 2007-10-10 EP EP07821164.6A patent/EP2081935B1/en not_active Not-in-force
- 2007-10-10 BR BRPI0717833-6A2A patent/BRPI0717833A2/pt not_active Application Discontinuation
- 2007-10-10 US US12/445,170 patent/US8039476B2/en not_active Expired - Fee Related
- 2007-10-10 JP JP2009531843A patent/JP5171831B2/ja not_active Expired - Fee Related
- 2007-10-10 UY UY30637A patent/UY30637A1/es not_active Application Discontinuation
- 2007-10-10 KR KR1020097008394A patent/KR101418624B1/ko active IP Right Grant
- 2007-10-10 AR ARP070104479A patent/AR063231A1/es unknown
- 2007-10-11 CL CL200702928A patent/CL2007002928A1/es unknown
- 2007-10-11 TW TW096137954A patent/TWI391392B/zh not_active IP Right Cessation
-
2009
- 2009-04-23 NO NO20091625A patent/NO342008B1/no not_active IP Right Cessation
-
2011
- 2011-05-25 US US13/115,272 patent/US8273753B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2008043800A1 (en) | 2008-04-17 |
JP5171831B2 (ja) | 2013-03-27 |
ES2637137T3 (es) | 2017-10-11 |
EP2081935B1 (en) | 2017-05-24 |
US8273753B2 (en) | 2012-09-25 |
TWI391392B (zh) | 2013-04-01 |
AR063231A1 (es) | 2009-01-14 |
JP2010505914A (ja) | 2010-02-25 |
UY30637A1 (es) | 2008-05-02 |
US20110224234A1 (en) | 2011-09-15 |
EP2081935A1 (en) | 2009-07-29 |
RU2009117716A (ru) | 2010-11-20 |
BRPI0717833A2 (pt) | 2014-06-10 |
KR101418624B1 (ko) | 2014-07-15 |
RU2413729C2 (ru) | 2011-03-10 |
AU2007306319A1 (en) | 2008-04-17 |
SI2081935T1 (sl) | 2017-12-29 |
MX2009003571A (es) | 2009-04-14 |
US20100087451A1 (en) | 2010-04-08 |
KR20090077796A (ko) | 2009-07-15 |
CL2007002928A1 (es) | 2008-05-09 |
CN101622257B (zh) | 2013-03-27 |
TW200827360A (en) | 2008-07-01 |
EP1918290A1 (en) | 2008-05-07 |
AU2007306319B2 (en) | 2012-12-06 |
NO342008B1 (no) | 2018-03-12 |
PT2081935T (pt) | 2017-08-29 |
PL2081935T3 (pl) | 2018-04-30 |
CA2666653C (en) | 2014-12-30 |
CA2666653A1 (en) | 2008-04-17 |
US8039476B2 (en) | 2011-10-18 |
DK2081935T3 (en) | 2017-09-04 |
CN101622257A (zh) | 2010-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200745121A (en) | Chemical compound | |
EA200801998A1 (ru) | ПИРИДИН[3,4-b]ПИРАЗИНОНЫ | |
NZ599008A (en) | 2-amino-5, 5-difluoro-5, 6-dihydro-4h-oxazines as bace 1 and/or bace 2 inhibitors | |
BRPI0408990A (pt) | derivados de pirimidin-4-ona e sua utilização como moduladores da p38-cinase | |
MX2010006436A (es) | Derivados peptidos mimeticos de eritropoyetina y sus sales farmaceuticas, su preparacion y usos. | |
ATE496021T1 (de) | Kristalline formen von (-)-(1r,2r)-3-(3- dimethylamino-1-ethyl-2-methylpropyl)- phenolhydrochlorid zur verwendung als aktivstoff in pharmazeutischen zubereitungen | |
NZ593295A (en) | Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinase inhibitor | |
EA201170741A1 (ru) | Производные n-{[(1r,4s,6r)-3-(2-пиридинилкарбонил)-3-азабицикло[4.1.0]гепт-4-ил]метил}-2-гетероариламина и их применения | |
UY30183A1 (es) | Derivados de quinolina | |
TW200745111A (en) | New compounds | |
NO20080186L (no) | Heterosykliske aspartylproteaseinhibitorer, fremstilling og anvendelse derav | |
BR122013028012B8 (pt) | composto de ciclopentano de pirimidila hidroxilado e metoxilado, sua composição farmacêutica e seu método de preparação | |
WO2007050587A3 (en) | Therapeutic compositions and methods | |
BRPI0406762A (pt) | Derivados de n-(1-benzil-2-oxo-2-(1-piperazinil)etil)-1-piperidincarb oxamida e compostos relacionados como antagonistas de cgrp, para tratamento de dores de cabeça | |
JO2770B1 (en) | Organic compounds | |
TW200639156A (en) | New compounds | |
NO20061575L (no) | Fremgangsmate for fremstilling av renzapride og mellomprodukter derav | |
CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
DK1869038T3 (da) | Substituerede 5,6,7,8-tetrahydro-imidazol[1,2-a]pyridin-2-ylamin-forbindelser og deres anvendelse til fremstilling af lægemidler | |
NO20091625L (no) | Polymorf B pa N-(2-fluoro-5-[3-(tiopen-2-karbonyl)-pyrazolo[1,5-A]pyrimidin-7-yl]-fenyl)-N-metylacetamid | |
TW200626581A (en) | Compounds, compositions containing them, preparation thereof and uses thereof | |
NO20084177L (no) | Substituerte Imidazo[2,1-B]thiazolforbindelser og deres anvendelse for produksjon av legemidler | |
DE602006009556D1 (de) | Chinolin-derivate zur behandlung von mglur5-rezeptor-vermittelten erkrankungen | |
NO20070550L (no) | Fremgangsmate for fremstilling av pyrrolotriazinforbindelser | |
TW200942529A (en) | Pyrrolidinyl derivatives and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |